InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Bizzari Jean-Pierre, Director. Officer active across 3 companies, notably Halozyme Therapeutics, INC.. In total, 12 disclosures have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €1.2m. Activity tracked since 5 May 2021. The latest transaction was filed on 1 June 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Bizzari Jean-Pierre
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
3,135 sharesCommon StockSEC:0001104659-26-075281:0
45,000 shares0Common SharesSEC:0001628280-26-040488:0
12,600 shares@ US$3.0836.7% of flowCommon SharesSEC:0001628280-26-040488:1
12,600 shares@ US$3.5842.7% of flowCommon SharesSEC:0001628280-25-031891:0
1,045 shares0Common StockSEC:0001104659-25-057806:0
40,000 shares0Common SharesSEC:0001628280-25-029735:0
6,995 shares@ US$2.8920.7% of flowCommon SharesSEC:0001628280-24-028992:0
40,000 shares0Common SharesSEC:0001628280-24-028355:0
8,065 shares0Common StockSEC:0001415889-23-007687:0
6,206 shares0Restricted Stock UnitsSEC:0001179110-22-002906:0
35,000 shares@ US$41.013100.0% of flowCommon StockSEC:0001179110-21-008418:0
5,230 shares0Restricted Stock UnitsSEC:0001179110-21-004969:0
12 of 12 declarations
About Bizzari Jean-Pierre
Jean-Pierre Bizzari is a Director at Halozyme Therapeutics, Inc. He brings valuable expertise in corporate governance and business strategy. His role involves overseeing the company's operations and contributing to strategic decision-making. With a strong background in the biopharmaceutical sector, he is involved in developing innovative solutions to improve patient health.
